Search - tctmd.com

Displaying 141 - 160 of 279

Sort: Relevancy | Date

Presentation TCT 2018

What is the Future of Bioresorbable Scaffolds?

Presenter: Jeroen J. Bax, Stephan Windecker, Michael Haude

September 21, 2018

Presentation TCT 2018

Clinical Performance of a Novel Sirolimus-Coated Balloon - Preliminary Data from the Worldwide EASTBOURNE Registry (Envision Scientific)

Presenter: Bernardo Cortese

September 21, 2018

Presentation TCT 2018

Treatment of Coronary Drug Eluting Stent Restenosis by a Sirolimus or a Paclitaxel Coated Balloon (B. Braun)

Presenter: Azman Wan Ahmad

September 21, 2018

Presentation TCT 2018

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 3-Year Clinical Follow-Up (Caliber)

Presenter: Juan F. Granada

September 21, 2018

News Daily News

PCI in Nonagenarians Rising as Focus Shifts to Frailty Over Age

Yael L. Maxwell

September 18, 2018

Presentation ESC 2018

Drug-Coated Balloons for Small Coronary Artery Disease: BASKET-SMALL 2

Presenter: Raban V. Jeger

August 31, 2018

Presentation ESC 2018

Outcomes of 10.312 Patients Treated with Everolimus-eluting Bioresorbable Scaffolds During Daily Clinical Practice: Results from the European Absorb Consortium

Presenter: Holger M. Nef

August 29, 2018

Presentation ESC 2018

ISAR-Absorb MI: A Prospective, Randomized Trial of BVS vs EES in Patients Undergoing Coronary Stenting for Myocardial Infarction

Presenter: Robert Byrne

August 29, 2018

News Conference News ESC 2018

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

Todd Neale

August 28, 2018

News Conference News ESC 2018

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

Michael O'Riordan

August 28, 2018

News Conference News ESC 2018

GLOBAL LEADERS: Ticagrelor Monotherapy Fails to Beat Conventional DAPT After PCI

Michael O'Riordan

August 27, 2018

Presentation ESC 2018

The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX

Presenter: Marco Valgimigli

August 26, 2018

News Conference News ESC 2018

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

Michael O'Riordan

August 25, 2018

News Daily News

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

Michael O'Riordan

August 23, 2018

News Daily News

Cancelled Cath Lab Activations and Timely Reperfusion: A ‘Balancing Act’

Michael O'Riordan

August 21, 2018

News Daily News

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

Yael L. Maxwell

August 17, 2018

Presentation

Impact of High On-Aspirin Platelet Reactivity on Outcomes Following Successful DES Implant

August 17, 2018

News Daily News

ADAPT-DES: High On-Aspirin Platelet Reactivity Not Related to PCI Outcomes

Todd Neale

August 17, 2018

News Daily News

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

Michael O'Riordan

August 13, 2018

$A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years$

News Daily News

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

Yael L. Maxwell

August 10, 2018

Advertisement

What is the Future of Bioresorbable Scaffolds?

Clinical Performance of a Novel Sirolimus-Coated Balloon - Preliminary Data from the Worldwide EASTBOURNE Registry (Envision Scientific)

Treatment of Coronary Drug Eluting Stent Restenosis by a Sirolimus or a Paclitaxel Coated Balloon (B. Braun)

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 3-Year Clinical Follow-Up (Caliber)

PCI in Nonagenarians Rising as Focus Shifts to Frailty Over Age

Drug-Coated Balloons for Small Coronary Artery Disease: BASKET-SMALL 2

Outcomes of 10.312 Patients Treated with Everolimus-eluting Bioresorbable Scaffolds During Daily Clinical Practice: Results from the European Absorb Consortium

ISAR-Absorb MI: A Prospective, Randomized Trial of BVS vs EES in Patients Undergoing Coronary Stenting for Myocardial Infarction

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

GLOBAL LEADERS: Ticagrelor Monotherapy Fails to Beat Conventional DAPT After PCI

The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

Cancelled Cath Lab Activations and Timely Reperfusion: A ‘Balancing Act’

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

Impact of High On-Aspirin Platelet Reactivity on Outcomes Following Successful DES Implant

ADAPT-DES: High On-Aspirin Platelet Reactivity Not Related to PCI Outcomes

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content